About Sequenta
Sequenta is a venture funded biotech company dedicated to the discovery and development of clinical diagnostics based on a revolutionary new platform for understanding immune system status. A profound revolution in the cost of DNA sequencing has enabled the company to develop brand new approaches to measuring the most variable part of the human genome: the immune cell receptor genes. The incredible diversity created by these genes are at the heart of a large number of conditions critical to human health and disease allowing the company to be in a position to inform a large number of clinical decisions using a single powerful assay. The company was founded in 2008 by entrepreneurs who previously founded ParaAllele BioScience, a successful startup company sold to Affymetrix in 2005.
|
|
|
1-10 employees
View all Sequenta employees
|
|
Biotechnology Research
|
|
650-243-3900
|
|
San Francisco, California
|
|
2008
|
Sequenta Alternatives
Frequently Asked Questions about Sequenta
The decision makers in Sequenta are Chris Wade, Thomas Willis, etc. Click to Find Sequenta decision makers emails.
Sequenta Staff Directory
Search Sequenta Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
